Which term refers to the official review of documents, facilities, and records by a regulatory authority?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Which term refers to the official review of documents, facilities, and records by a regulatory authority?

Explanation:
An inspection is an official regulatory review of documents, facilities, and records conducted by a regulatory authority. Regulators such as the FDA or EMA perform inspections to verify compliance with GCP and applicable laws, confirm that trial activities match the protocol, and ensure that essential records, facilities, and staff qualifications are adequate. Inspections may involve examining source documents, the trial master file, training records, equipment, and storage areas, and may include interviews with staff. The purpose is to determine whether the trial was conducted in accordance with regulatory requirements and to identify any deficiencies for corrective action. This differs from essential documents, which are the records used to demonstrate trial quality and compliance; informed consent, which is the participant’s voluntary agreement after information is provided; and direct access, which is the right of sponsors, investigators, monitors, or regulators to access source data and records as needed.

An inspection is an official regulatory review of documents, facilities, and records conducted by a regulatory authority. Regulators such as the FDA or EMA perform inspections to verify compliance with GCP and applicable laws, confirm that trial activities match the protocol, and ensure that essential records, facilities, and staff qualifications are adequate. Inspections may involve examining source documents, the trial master file, training records, equipment, and storage areas, and may include interviews with staff. The purpose is to determine whether the trial was conducted in accordance with regulatory requirements and to identify any deficiencies for corrective action. This differs from essential documents, which are the records used to demonstrate trial quality and compliance; informed consent, which is the participant’s voluntary agreement after information is provided; and direct access, which is the right of sponsors, investigators, monitors, or regulators to access source data and records as needed.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy